case no.
|
gender/
age at diagnosis
|
studied
material
|
de novo/
inherited
|
GTG-banding result
grade of mosaicism
|
final result of the sSMC
|
test
methods
|
clinical symptoms
|
Reference
|
19-
U-
1 |
female/
prenatal |
AF |
de novo |
47,XX,+mar[45]/
46,XX[10] |
min(19)(:p12→q13.1:) |
M-FISH;
cenM;
MCB |
AMA; no
ultrasound abnormalities;TOP |
{1} case 28 |
19-
U-
2
|
male/
prenatal |
AF |
de novo |
47,XY,+mar[38]/
46,XY[17] |
r(19)(::p13.11→
q13.11-12::)[16]/
r(19;19)(::p13.11→
q13.11-12:
:p13.11→q13.11~
12::)[2]/
min(19)(:p13.11→
q13.11-12:)[5] |
cenM;
subcenM |
AMA; no
ultrasound abnormalities in week 15;
spontaneous abortion after amniocentesis |
{0} provided from Germany |
19-
U-
3 |
male/
prenatal |
AF |
de novo? |
47,XY,+mar[100%] |
r(19)(::p12→q12::) |
midi |
n.a. |
{9} case 4 |
19-
U-
4 |
male/
prenatal |
AF |
de novo |
47,XY,+r[17%]/
46,XY[83%] |
r(19) |
centromeric
probes and wcp |
TOP; autopsy
result normal |
{10} case 5 |
19-
U-
5 |
female/
prenatal |
AF |
de novo |
47,XX,+mar[10%]/
46,XX[90%] |
min(19)(:p13.11→q12:) |
cenM;
subcenM |
AMA; no
ultrasound abnormalities; TOP - no
additional information available |
{0} provided from Germany |
19-
U-
6 |
male/
prenatal |
AF |
de novo |
47,XY,dup(21)(q22.2q21.1),+r[18]/
46,XY,dup(21)(q22.2q21.1)[32] |
r(19)(::p13.11→q13.2::)*
sSMC derived from a maternal chromosome 19 |
different
FISH probes, micro satellite analysis;
UPD-test |
see below |
{8} case 3
{42} |
AMA; Baby
born by cesarean section at 40th week
without complications, with hypotonia,
dysmorphic craniofacial features including
microcephaly, hypertelorism, upward slanting
palpebral fissures, deep palmar and plantar
crease; delayed myelinisation, psychomotor
development moderately delayed at 9m. No
Down syndrome features, which is in
concordance with the lack of the DSCR. |
19-
U-
7 |
female/
prenatal |
AF, PBL
(EKF-
cellbank) |
de novo |
47,XX,+mar[10]/
46,XX[30] |
min(19)(:p13.11→q12:) FISH-data:
26.7-at least to 33.3MB |
cenM;
subcenM; UPD-test |
see below |
{23} case 13 |
possible
hypotrophy in US, parents 31y and
non-consanguineous. Already one healthy 4 y
old girl. Amniocentesis due to abnormal
maternal screening (1/100); TOP, no autopsy
but fetus without abnormalities |
19-
U-
8 |
n.a./
prenatal |
AF |
de novo |
47,+mar[100%] |
r(19) |
M-FISH; wcp
19 |
abnormal in
1st ultrasound. hydramnios |
{21} case 4 |
19-
U-
9 |
n.a./
prenatal |
AF |
de novo |
47,+mar[100%] |
r(19) |
M-FISH; wcp
19 |
maternal
serum screen test; TOP |
{21} case 12 |
19-
U-
10 |
male/
prenatal |
chord blood |
de novo |
47,XY,+mar[28]/
46,XY[4] |
r(19)(::p13.1→q13.1::)[17]/
r(19;19)(::p13.1→q13.1:
:p13.1→q13.1::)[4]
FISH-data: breaks between 10.61-22.66
and 48.31-57.56 MB |
M-FISH;
subcenM, PCL-FISH |
enhanced
nuchal translucency, TOP |
{50} case 20 |
19-
U-
11 |
female/
prenatal |
AF |
de novo |
47,XY,+mar[34%]/
46,XY[66%] |
r(19)(::p11.1→q12::) |
M-FISH;
subcenM; UPD-test |
AMA, patient
lost during follow up |
{0} provided from Germany |
19-
U-
12 |
female/
prenatal |
AF |
de novo |
47,XY,+mar[40%]/
46,XY[60%] |
min(19)(:p11.1→q13.1~
13.2:)[16]/
r(19)(::p11.1→q13.1~
13.2::)[8]/
r(19;19)(::p11.1→q13.1~13.2:
:p11.1→q13.1~13.2::)[1] |
cenM-FISH;
subcenM |
AMA, patient
lost during follow up |
{0} provided from Germany |
19-
U-
13 |
n.a./
prenatal |
AF |
n.a. |
47,+mar[17%]/
46[83%] |
r(19) |
wcp19; cep19 |
AMA. no
further information available TOP |
{37} case 13 |
19-
U-
14 |
n.a./
prenatal |
AF |
n.a. |
47,+mar[60%]/
46[40%] |
min(19)(:p12→q13.1:)
aCGH: 24.08-40.50 |
wcp19;
cep19, subcenM;
aCGH |
n.a. |
n.a. |
19-
U-
15 |
see
19-Uc-1 |
19-
U-
16 |
male/
prenatal |
AF |
n.a. |
47,XY,+mar[100%] |
min(19)(:p13.11→q11:) |
cenM,
subcenM |
n.a. |
{0} provided from Portugal |
19-
U-
17 |
n.a./
prenatal |
AF |
n.a. |
47,+mar[100%] |
min(19)(:p12→q12:)
aCGH: 33.10-33.59 |
cenM;
subcenM;
aCGH |
AMA; no US
abnormalities. No further info available |
{0} provided from Germany |
19-
U-
18 |
female/
prenatal |
AF |
n.a. |
47,+mar[?100%] |
mar(19) |
SKY |
n.a. |
{48} case F0534481 |
19-
U-
19 |
male/
prenatal |
AF |
de novo |
47,XY,+mar[56]/
46,XY[47] |
mar(19)(p1?2→q13.11)
aCGH: 32.54-37.60 |
aCGH |
normal
sonography, TOP |
{49} |
19-
U-
20 |
see
19-Ud-3 |
19-
U-
21 |
male/
9y |
PBL
(EKF-
cellbank) |
n.a. |
47,XY,+mar[5]/
46,XY[50] |
min(19)(:p12→q12:) |
cep; subcenM |
n.a. |
GGB0358M, 2236; provided
by Teleton foundation, Italy |
19-
U-
22 |
male/
prenatal |
CH; AF |
n.a. |
CH:
47,XY,+mar[10%]/
46,XY[90%]
AF: 20% |
min(19)(:p12→q13.2:)
aCGH (hg19) break in 19 q: 42,723,970 |
aCGH
subcenM |
AMA, TOP |
{0} provided from Greece |
19-
U-
23 |
male/
prenatal |
AF |
de novo
|
47,XY,+mar[5]/
46,XY[26] |
min(19)(:p13.11→q11:)
arr[GRCh37] 19p13.11p12(16,897,821_
24,340,741)x2~3 |
aCGH
subcenM |
AMA |
{0}
provided from Germany
|
19-
U-
24 |
female/
prenatal |
AF |
n.a.
|
47,XX,+mar[12]/
46,XX[8] |
min(19)(:p12→q12:) |
cenM
subcenM |
AMA |
{0}
provided from Germany
|